US equities
|
META
$622.80
▼-1.23%
TSLA
$401.36
▲+2.49%
MU
$914.85
▲+1.23%
NVDA
$216.01
▲+0.00%
SPCX
$148.44
▲+1.05%
AMD
$547.38
▲+3.03%
INTC
$92.22
▲+1.93%
SNDK
$1,292.34
▲+2.93%
META
$622.80
▼-1.23%
TSLA
$401.36
▲+2.49%
MU
$914.85
▲+1.23%
NVDA
$216.01
▲+0.00%
SPCX
$148.44
▲+1.05%
AMD
$547.38
▲+3.03%
INTC
$92.22
▲+1.93%
SNDK
$1,292.34
▲+2.93%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
MindMed
Small Cap
Psychedelics
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
MindMed
Small Cap
NDAQ
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
News
Jordan Fried
Interview
From
Benzinga